Breast cancer angiogenesis

A quantitative morphologic and doppler imaging study

Wei Jei Lee, Jan Show Chu, Shyh Jinn Houng, Mei Fu Chung, Shin Ming Wang, Kai Mo Chen

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Background: Tumor growth and metastases require the development of new vessels (angiogenesis). Angiogenesis, assessed by microvessel count using immunocytochemical stain of endothelial cells, has been shown to predict metastases and correlate with early death. Recently developed color Doppler mapping can detect the "tumor flow signals" in breast cancer and help to distinguish it from benign lesions. The question is, does this tumor vascularization assessed by color Doppler mapping correlate with the angiogenesis assessed by immunocytochemistry? Methods: Eighty-four patients admitted for breast surgery were studied. The final diagnosis was made by pathology for 52 malignancies and 32 benign lesions. The color Doppler mapping of the breast lesion was made preoperatively. The following parameters were assessed: (a) vessel location (peripheral or central); (b) density of color Doppler signals; and (c) maximum systolic velocity. Tumor angiogenesis was assessed by microvessel count under light microscopy using the platelet/endothelial cell adhesion molecule antibodies (CD31) method. The correlation between maximum velocity and microvessel count of breast cancer was examined. The clinical significance of maximum flow velocity of breast cancer with various clinicopathologic factors was assessed. Results: Color signals were detected in 48 cases of 52 malignancies (92%). All tumors demonstrated signals at the periphery of the lesion but in only 13 (27%) were the signals detected within the tumor. Color signals were scored as + + or + + + in 44 (92%) patients. Pulsed wave blood flow was shown in all these 48 tumors, with maximum velocities varying from 4 to 36 cm/s. Among the 32 benign lesions, color signals were detected in 10 (31%) and all were peripheral and scored subjectively as +. Evaluation of these color Doppler mapping parameters shows no significant correlation with microvessel counts using CD31 monoclonal antibodies. However, there was a positive association (p

Original languageEnglish
Pages (from-to)246-251
Number of pages6
JournalAnnals of Surgical Oncology
Volume2
Issue number3
DOIs
Publication statusPublished - May 1995
Externally publishedYes

Fingerprint

Breast Neoplasms
Color
Microvessels
Neoplasms
Breast
Endothelial Cells
Neoplasm Metastasis
Cell Adhesion Molecules
Microscopy
Coloring Agents
Blood Platelets
Immunohistochemistry
Monoclonal Antibodies
Pathology
Light
Antibodies
Growth

Keywords

  • Angiogenesis
  • Breast cancer
  • Color Doppler sonography

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Breast cancer angiogenesis : A quantitative morphologic and doppler imaging study. / Lee, Wei Jei; Chu, Jan Show; Houng, Shyh Jinn; Chung, Mei Fu; Wang, Shin Ming; Chen, Kai Mo.

In: Annals of Surgical Oncology, Vol. 2, No. 3, 05.1995, p. 246-251.

Research output: Contribution to journalArticle

Lee, Wei Jei ; Chu, Jan Show ; Houng, Shyh Jinn ; Chung, Mei Fu ; Wang, Shin Ming ; Chen, Kai Mo. / Breast cancer angiogenesis : A quantitative morphologic and doppler imaging study. In: Annals of Surgical Oncology. 1995 ; Vol. 2, No. 3. pp. 246-251.
@article{6d541024eb074a179629d55e6847dad4,
title = "Breast cancer angiogenesis: A quantitative morphologic and doppler imaging study",
abstract = "Background: Tumor growth and metastases require the development of new vessels (angiogenesis). Angiogenesis, assessed by microvessel count using immunocytochemical stain of endothelial cells, has been shown to predict metastases and correlate with early death. Recently developed color Doppler mapping can detect the {"}tumor flow signals{"} in breast cancer and help to distinguish it from benign lesions. The question is, does this tumor vascularization assessed by color Doppler mapping correlate with the angiogenesis assessed by immunocytochemistry? Methods: Eighty-four patients admitted for breast surgery were studied. The final diagnosis was made by pathology for 52 malignancies and 32 benign lesions. The color Doppler mapping of the breast lesion was made preoperatively. The following parameters were assessed: (a) vessel location (peripheral or central); (b) density of color Doppler signals; and (c) maximum systolic velocity. Tumor angiogenesis was assessed by microvessel count under light microscopy using the platelet/endothelial cell adhesion molecule antibodies (CD31) method. The correlation between maximum velocity and microvessel count of breast cancer was examined. The clinical significance of maximum flow velocity of breast cancer with various clinicopathologic factors was assessed. Results: Color signals were detected in 48 cases of 52 malignancies (92{\%}). All tumors demonstrated signals at the periphery of the lesion but in only 13 (27{\%}) were the signals detected within the tumor. Color signals were scored as + + or + + + in 44 (92{\%}) patients. Pulsed wave blood flow was shown in all these 48 tumors, with maximum velocities varying from 4 to 36 cm/s. Among the 32 benign lesions, color signals were detected in 10 (31{\%}) and all were peripheral and scored subjectively as +. Evaluation of these color Doppler mapping parameters shows no significant correlation with microvessel counts using CD31 monoclonal antibodies. However, there was a positive association (p",
keywords = "Angiogenesis, Breast cancer, Color Doppler sonography",
author = "Lee, {Wei Jei} and Chu, {Jan Show} and Houng, {Shyh Jinn} and Chung, {Mei Fu} and Wang, {Shin Ming} and Chen, {Kai Mo}",
year = "1995",
month = "5",
doi = "10.1007/BF02307031",
language = "English",
volume = "2",
pages = "246--251",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Breast cancer angiogenesis

T2 - A quantitative morphologic and doppler imaging study

AU - Lee, Wei Jei

AU - Chu, Jan Show

AU - Houng, Shyh Jinn

AU - Chung, Mei Fu

AU - Wang, Shin Ming

AU - Chen, Kai Mo

PY - 1995/5

Y1 - 1995/5

N2 - Background: Tumor growth and metastases require the development of new vessels (angiogenesis). Angiogenesis, assessed by microvessel count using immunocytochemical stain of endothelial cells, has been shown to predict metastases and correlate with early death. Recently developed color Doppler mapping can detect the "tumor flow signals" in breast cancer and help to distinguish it from benign lesions. The question is, does this tumor vascularization assessed by color Doppler mapping correlate with the angiogenesis assessed by immunocytochemistry? Methods: Eighty-four patients admitted for breast surgery were studied. The final diagnosis was made by pathology for 52 malignancies and 32 benign lesions. The color Doppler mapping of the breast lesion was made preoperatively. The following parameters were assessed: (a) vessel location (peripheral or central); (b) density of color Doppler signals; and (c) maximum systolic velocity. Tumor angiogenesis was assessed by microvessel count under light microscopy using the platelet/endothelial cell adhesion molecule antibodies (CD31) method. The correlation between maximum velocity and microvessel count of breast cancer was examined. The clinical significance of maximum flow velocity of breast cancer with various clinicopathologic factors was assessed. Results: Color signals were detected in 48 cases of 52 malignancies (92%). All tumors demonstrated signals at the periphery of the lesion but in only 13 (27%) were the signals detected within the tumor. Color signals were scored as + + or + + + in 44 (92%) patients. Pulsed wave blood flow was shown in all these 48 tumors, with maximum velocities varying from 4 to 36 cm/s. Among the 32 benign lesions, color signals were detected in 10 (31%) and all were peripheral and scored subjectively as +. Evaluation of these color Doppler mapping parameters shows no significant correlation with microvessel counts using CD31 monoclonal antibodies. However, there was a positive association (p

AB - Background: Tumor growth and metastases require the development of new vessels (angiogenesis). Angiogenesis, assessed by microvessel count using immunocytochemical stain of endothelial cells, has been shown to predict metastases and correlate with early death. Recently developed color Doppler mapping can detect the "tumor flow signals" in breast cancer and help to distinguish it from benign lesions. The question is, does this tumor vascularization assessed by color Doppler mapping correlate with the angiogenesis assessed by immunocytochemistry? Methods: Eighty-four patients admitted for breast surgery were studied. The final diagnosis was made by pathology for 52 malignancies and 32 benign lesions. The color Doppler mapping of the breast lesion was made preoperatively. The following parameters were assessed: (a) vessel location (peripheral or central); (b) density of color Doppler signals; and (c) maximum systolic velocity. Tumor angiogenesis was assessed by microvessel count under light microscopy using the platelet/endothelial cell adhesion molecule antibodies (CD31) method. The correlation between maximum velocity and microvessel count of breast cancer was examined. The clinical significance of maximum flow velocity of breast cancer with various clinicopathologic factors was assessed. Results: Color signals were detected in 48 cases of 52 malignancies (92%). All tumors demonstrated signals at the periphery of the lesion but in only 13 (27%) were the signals detected within the tumor. Color signals were scored as + + or + + + in 44 (92%) patients. Pulsed wave blood flow was shown in all these 48 tumors, with maximum velocities varying from 4 to 36 cm/s. Among the 32 benign lesions, color signals were detected in 10 (31%) and all were peripheral and scored subjectively as +. Evaluation of these color Doppler mapping parameters shows no significant correlation with microvessel counts using CD31 monoclonal antibodies. However, there was a positive association (p

KW - Angiogenesis

KW - Breast cancer

KW - Color Doppler sonography

UR - http://www.scopus.com/inward/record.url?scp=0029300576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029300576&partnerID=8YFLogxK

U2 - 10.1007/BF02307031

DO - 10.1007/BF02307031

M3 - Article

VL - 2

SP - 246

EP - 251

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 3

ER -